Why is Warner Bros. Discovery considering a sale?
How did OpenAI's new browser impact Google stock?
What caused Beyond Meat's recent stock surge?
Why is General Motors raising its full-year outlook?
How is the government shutdown affecting the economy?
What are the effects of the new $100K H-1B visa fee?
Why did gold prices plunge after recent highs?
Sanofi's Rezurock Approval Stumbles In EU For Chronic Graft-Vs-Host Disease
benzinga.com/news/health-care/25/10/48281451/sanofis-rezurock-approval-stumbles-in-eu-for-chronic-graft-vs-host-disease
On Friday, the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) issued a negative opinion for Sanofi SA’s (NASDAQ:SNY) Rezurock (belumosudil).
The French drug maker was seeking approval for Rezurock for the third-line treatment of adults and pediatric…
This story appeared on benzinga.com, 2025-10-17 17:03:37.